FDA reviews Avandia safety data
Tuesday, February 23, 2010 - 09:07
in Health & Medicine
WASHINGTON, Feb. 23 (UPI) -- The U.S. Food and Drug Administration says it is reviewing data from a long-term study concerning possible cardiovascular risks with the drug Avandia.